The Department of Defense Neurofibromatosis Research Program is offering the Clinical Trial Award to swiftly initiate clinical trials that could significantly impact the treatment or management of NF. Projects may include testing new products, drugs, devices, and technologies, from proof-of-concept trials to large-scale trials to determine efficacy in patient populations. Applications closing on July 9, 2020.
Opportunity ID: 325883
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-20-NFRP-CTA |
| Funding Opportunity Title: | DoD Neurofibromatosis, Clinical Trial Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 30, 2020 |
| Last Updated Date: | Mar 30, 2020 |
| Original Closing Date for Applications: | Jul 09, 2020 |
| Current Closing Date for Applications: | Jul 09, 2020 |
| Archive Date: | Aug 08, 2020 |
| Estimated Total Program Funding: | $1,600,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: |
The NFRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of NF. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, Phase 0), to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
CDMRP Help Desk
Phone: 301-682-5507 Email: help@eBRAP.org Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 325883 Full Announcement-FY20 NFRP CTA -> NFRP_FY20_CTA_PA_GG.PDF
Packages
| Agency Contact Information: | CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00260631 | Mar 30, 2020 | Jul 09, 2020 | View |
Package 1
Mandatory forms
325883 RR_SF424_2_0-2.0.pdf
325883 AttachmentForm_1_2-1.2.pdf
325883 RR_PersonalData_1_2-1.2.pdf
325883 RR_KeyPersonExpanded_2_0-2.0.pdf
325883 RR_Budget_1_4-1.4.pdf
325883 PerformanceSite_2_0-2.0.pdf
Optional forms
325883 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
